Hutchmed (China) Limited

Report Publication Announcement • Apr 9, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7825B

Hutchison China Meditech Limited

09 April 2013

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

2012 Annual Report and

Notice of Annual General Meeting

London: Tuesday, 9 April 2013: Chi-Med today announces that its 2012 Annual Report together with the Notice of Annual General Meeting and the Proxy Form have been posted to shareholders.  The documents can be accessed from the website of Chi-Med (www.chi-med.com).

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:     +852 2121 8200
Panmure Gordon (UK) Limited	Telephone:     +44 20 7886 2500
Richard Gray Andrew Potts Grishma Patel
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:     +44 20 7638 9571 Mobile:           +44 7973 611 888 Mobile:           +44 7967 566 919

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGIGDSXSGBGXI